
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.410 | 0.770 | 0.360 |
Stocks | 98.840 | 98.840 | 0.000 |
Preferred | 0.740 | 0.740 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 19.474 | 20.191 |
Price to Book | 5.653 | 4.123 |
Price to Sales | 2.474 | 2.474 |
Price to Cash Flow | 17.920 | 16.533 |
Dividend Yield | 1.424 | 1.364 |
5 Years Earnings Growth | 10.317 | 12.128 |
Number of long holdings: 100
Number of short holdings: 40
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 9.17 | 873.68 | +0.06% | |
UnitedHealth | US91324P1021 | 8.35 | 466.42 | -7.17% | |
AbbVie | US00287Y1091 | 6.14 | 202.08 | +0.60% | |
J&J | US4781601046 | 5.74 | 162.30 | +1.64% | |
Thermo Fisher Scientific | US8835561023 | 4.66 | 532.55 | -0.98% | |
AstraZeneca | GB0009895292 | 4.65 | 11,708.0 | +1.02% | |
Boston Scientific | US1011371077 | 4.28 | 104.49 | -0.83% | |
Bristol-Myers Squibb | US1101221083 | 3.66 | 55.83 | +0.07% | |
Stryker | US8636671013 | 3.64 | 382.78 | -0.94% | |
Medtronic | IE00BTN1Y115 | 3.60 | 89.94 | +2.27% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
JPM Global Income A acc EUR | 18.14B | 1.81 | 0.39 | 2.08 | ||
LU0740858492 | 18.14B | 1.78 | 0.04 | 1.72 | ||
JPMorgan Global Income A Div EUR | 18.14B | 1.81 | 0.39 | 2.08 | ||
JPM Global Income Fund A Mth EUR | 18.14B | 1.80 | 0.38 | - | ||
JPMorgan Global Income D div EUR | 18.14B | 1.78 | 0.04 | 1.72 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review